AlzPED: An Open Science Tool Raising the Standards for Preclinical Testing of Candidate Therapeutics in Alzheimer’s Disease Animal Models

IF 5.6 2区医学 Q1 CLINICAL NEUROLOGY

Neurotherapeutics Pub Date : 2024-07-01 DOI:10.1016/j.neurot.2024.e00407

Jaya Viswanathan Ph.D., Maria Fe Lanfranco Gallofre Ph.D., Zane Martin Ph.D., Suzana Petanceska Ph.D., Shreaya Chakroborty Ph.D., Lorenzo Refolo Ph.D.

引用次数: 0

查看原文本刊更多论文

AlzPED：提高阿尔茨海默病动物模型候选疗法临床前测试标准的开放式科学工具

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Neurotherapeutics 医学-神经科学

CiteScore

11.00

自引率

3.50%

发文量

154

审稿时长

6-12 weeks

期刊介绍： Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.